Senate panel hears of conflict in drugmaker-doctor relations

06/27/2007 | Washington Post, The · NYTimes.com

Nearly two-thirds of the cost of continuing education courses in medicine is sponsored by drugmakers, according to testimony at a Senate committee hearing. A pharmaceutical industry executive said funding of continuing medical education is an important way to give physicians the latest medical and scientific research news.

View Full Article in:

Washington Post, The · NYTimes.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
PacificSource
Springfield, OR
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA